Alex Franzusoff is the founder of PACT Pharma. PACT Pharma has raised $200M in total funding. Latest round: Series C. Backed by Vida Ventures.
Alex Franzusoff is the Chief Executive Officer of PACT Pharma, a company dedicated to developing personalized NeoTCR-T cell therapies for cancer patients. Under his leadership, PACT Pharma closed an oversubscribed $75 million Series C financing round in January 2020. The company focuses on eradicating solid tumors and plans to expand its clinical programs and open a new manufacturing facility in South San Francisco.
Full founder directory · Investor directory · Company funding database · Fundraising library